Increased glutamate and glutamine levels and their relationship to astrocytes and dopaminergic transmissions in the brains of adults with autism.

Researchers used brain scans to study brain chemistry differences in autistic adults. They found higher levels of certain brain chemicals (glutamate and glutamine) that make brain cells more active in people with autism. This suggests that autistic brains may have an imbalance where some areas are overly active. The study also found that brain cells called astrocytes, which support neurons, may be more active in autism.

These findings help explain some of the neurological differences seen in autism.

This neuroimaging study examined brain chemistry in 18 male adults with high-functioning autism compared to 20 typically developing controls using magnetic resonance spectroscopy and PET scanning. Participants with autism showed significantly elevated levels of glutamate, glutamine, and myo-inositol in the anterior cingulate cortex, suggesting increased excitatory brain activity. The researchers found a positive correlation between glutamine and myo-inositol levels in the autism group, indicating potential astrocyte activation. Additionally, both groups showed negative correlations between dopamine D1 receptor binding and glutamine levels, suggesting an inhibitory relationship.

The findings support the hypothesis that autism involves disrupted excitation-inhibition balance, potentially due to enhanced glutamate-glutamine metabolism from astrocyte activation and altered dopaminergic signaling in key brain regions involved in social cognition and emotional processing.

Findings suggest potential biomarkers for autism-related brain differences and support excitation-inhibition imbalance theory. May inform future therapeutic targets focusing on glutamate regulation or astrocyte function. However, translation to clinical practice requires validation in larger, more diverse samples including females and varying support needs.

Small sample size (18 autism participants) limits generalizability. Study included only high-functioning males, restricting applicability to broader autism population. Cross-sectional design prevents causal inferences. Abstract lacks detailed methodology information about potential confounding factors or statistical controls.

Increased excitatory neuronal tones have been implicated in autism, but its mechanism remains elusive. The amplified glutamate signals may arise from enhanced glutamatergic circuits, which can be affected by astrocyte activation and suppressive signaling of dopamine neurotransmission. We tested this hypothesis using magnetic resonance spectroscopy and positron emission tomography scan withC-SCH23390 for dopamine D1 receptors in the anterior cingulate cortex (ACC). We enrolled 18 male adults with high-functioning autism and 20 typically developed (TD) male subjects.

The autism group showed elevated glutamate, glutamine, and myo-inositol (mI) levels compared with the TD group (p = 0.045, p = 0.044, p = 0.030, respectively) and a positive correlation between glutamine and mI levels in the ACC (r = 0.54, p = 0.020). In autism and TD groups, ACC D1 receptor radioligand binding was negatively correlated with ACC glutamine levels (r = - 0.55, p = 0.022; r = - 0.58, p = 0.008, respectively). The enhanced glutamate-glutamine metabolism might be due to astroglial activation and the consequent reinforcement of glutamine synthesis in autistic brains. Glutamine synthesis could underly the physiological inhibitory control of dopaminergic D1 receptor signals.

Our findings suggest a high neuron excitation-inhibition ratio with astrocytic activation in the etiology of autism.